These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6192967)

  • 1. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension.
    Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR
    Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator agents in pulmonary artery hypertension of systemic scleroderma].
    Phlippoteau C; Brenot F; Blétry O; Simmonneau G; Duroux P
    Rev Mal Respir; 1990; 7(3):249-54. PubMed ID: 2114030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L; Bogdan M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777
    [No Abstract]   [Full Text] [Related]  

  • 4. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of primary pulmonary hypertension with phentolamine].
    Heinrich U; Angehrn W; Steinbrunn W
    Schweiz Med Wochenschr; 1983 Jan; 113(4):145-8. PubMed ID: 6828847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tolazoline, nitroprusside, nitroglycerin, isoproterenol and hydralazine on pulmonary circulation early after heart valve replacement.
    Goenen MJ; Leenaert L; Petein M; Pouleur H; Jaumin P; Tremouroux J
    Thorac Cardiovasc Surg; 1982 Oct; 30(5):253-8. PubMed ID: 6183769
    [No Abstract]   [Full Text] [Related]  

  • 8. [The therapeutic modification of the primary vascular form of chronic cor pulmonale and of continuing pulmonary hypertension after commissurotomy for mitral stenosis. A comparison with control of the pulmonary artery pressure].
    Degenring FH
    Z Kreislaufforsch; 1970 Oct; 59(10):912-23. PubMed ID: 4395191
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
    Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
    Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator therapy in primary pulmonary hypertension.
    Elkayam U
    Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
    [No Abstract]   [Full Text] [Related]  

  • 11. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilators and pulmonary hypertension: where do we go from here?
    Rubin LJ
    Am Rev Respir Dis; 1987 Feb; 135(2):287. PubMed ID: 3813188
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nifedipine in the treatment of pulmonary hypertension. I--Primary pulmonary hypertension].
    Barreto SM; de Freitas FM
    Arq Bras Cardiol; 1986 May; 46(5):359-64. PubMed ID: 3551892
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hemodynamic response to vasodilators in primary pulmonary hypertension.
    Kulkarni H; Srinivas A; Vora A; Kerkar P; Dalvi B
    J Postgrad Med; 1996; 42(1):7-11. PubMed ID: 9715289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease.
    Dantzker DR; Bower JS
    Am Rev Respir Dis; 1981 Aug; 124(2):129-31. PubMed ID: 6789732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary pulmonary hypertension: current therapeutic prospectives].
    Pannarale G; Gaspardone A; Acconcia MC; Valente A
    Cardiologia; 1982 Sep; 27(9):883-94. PubMed ID: 6892464
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early pulmonary hypertension: current therapeutic prospectives].
    Pannarale G; Gaspardone A; Acconcia MC; Valente A
    Cardiologia; 1982 Sep; 27(9):883-94. PubMed ID: 6765450
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.